We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+16.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.82B
AUM Growth
+$1.31B
Cap. Flow
+$158M
Cap. Flow %
2.03%
Top 10 Hldgs %
19.27%
Holding
869
New
65
Increased
350
Reduced
240
Closed
81

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$43.7M
2
BMY icon
Bristol-Myers Squibb
BMY
+$30.4M
3
GILD icon
Gilead Sciences
GILD
+$28.3M
4
BIIB icon
Biogen
BIIB
+$26.7M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$25.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$75.2M
2
LOXO
Loxo Oncology, Inc
LOXO
+$28.1M
3
DHR icon
Danaher
DHR
+$27.9M
4
A icon
Agilent Technologies
A
+$26.4M
5
MKC icon
McCormick & Company Non-Voting
MKC
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 33.36%
2 Technology 15.96%
3 Financials 11.25%
4 Consumer Discretionary 8.98%
5 Communication Services 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FRC
501
DELISTED
First Republic Bank
FRC
$1.89M 0.02%
18,782
– –
LGND icon
502
Ligand Pharmaceuticals
LGND
$5.99B
$1.89M 0.02%
24,045
– –
SYRS
503
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1.86M 0.02%
20,400
– –
DLR icon
504
Digital Realty Trust
DLR
$70.9B
$1.86M 0.02%
15,602
+1,654
+12% +$185K
MCK icon
505
McKesson
MCK
$102B
$1.86M 0.02%
15,867
– –
LRCX icon
506
Lam Research
LRCX
$342B
$1.85M 0.02%
103,140
+6,680
+7% +$111K
DLTR icon
507
Dollar Tree
DLTR
$24.6B
$1.84M 0.02%
17,512
+1,130
+7% +$111K
PFG icon
508
Principal Financial Group
PFG
$23.9B
$1.84M 0.02%
36,603
-8,218
-18% -$407K
LVS icon
509
Las Vegas Sands
LVS
$32B
$1.83M 0.02%
30,056
+3,963
+15% +$233K
NVO
510
Novo Nordisk
NVO
$223B
$1.83M 0.02%
+70
New +$1.72K
VTR icon
511
Ventas
VTR
$49.1B
$1.82M 0.02%
28,599
+36
+0.1% +$2.25K
IEX icon
512
IDEX
IEX
$16.7B
$1.82M 0.02%
12,009
+991
+9% +$140K
OVV icon
513
Ovintiv
OVV
$16.6B
$1.82M 0.02%
50,205
+5,719
+13% +$196K
KSU
514
DELISTED
Kansas City Southern
KSU
$1.82M 0.02%
15,681
+756
+5% +$81.6K
CLX icon
515
Clorox
CLX
$12.1B
$1.82M 0.02%
11,320
+962
+9% +$149K
WDAY icon
516
Workday
WDAY
$37.8B
$1.8M 0.02%
9,359
+577
+7% +$105K
CDW icon
517
CDW
CDW
$18.2B
$1.8M 0.02%
18,697
-1,265
-6% -$113K
VNO icon
518
Vornado Realty Trust
VNO
$7.47B
$1.79M 0.02%
26,505
+1,837
+7% +$123K
DOV icon
519
Dover
DOV
$27.8B
$1.78M 0.02%
18,951
-6,017
-24% -$520K
LUMN icon
520
Lumen
LUMN
$6.25B
$1.75M 0.02%
146,263
-31,181
-18% -$433K
URBN icon
521
Urban Outfitters
URBN
$6.39B
$1.75M 0.02%
59,000
+47,000
+392% +$1.45M
ALLY icon
522
Ally Financial
ALLY
$13.3B
$1.74M 0.02%
63,334
-3,014
-5% -$78.7K
LNG icon
523
Cheniere Energy
LNG
$53.3B
$1.74M 0.02%
25,439
-5,296
-17% -$348K
DXC icon
524
DXC Technology
DXC
$1.74B
$1.73M 0.02%
26,922
+4,900
+22% +$313K
FAST icon
525
Fastenal
FAST
$55.7B
$1.73M 0.02%
107,560
-687,188
-86% -$10.3M
19 20
21
22 23

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2019 Portfolio in Review

As of Q1 2019, Candriam SCA held 869 positions worth $7.82B, up 20% from $6.51B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Candriam SCA's Q1 2019 filing shows 65 new, 350 increased, 240 reduced and 81 closed positions. Its largest new stake was Baozun: 640,000 shares worth $26.6M. The largest sale was Celgene Corp, an estimated $75.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2019 buy was Baozun: 640,000 shares worth $26.6M.
  • Candriam SCA added most to Merck in Q1 2019, an estimated $43.7M increase.
  • Candriam SCA's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $75.2M.
  • Candriam SCA fully exited Loxo Oncology, Inc in Q1 2019, selling an estimated $28.1M.
  • Candriam SCA's ten largest holdings make up 19% of its $7.82B portfolio in Q1 2019.
  • Candriam SCA opened 65 new positions and closed 81 in Q1 2019.
  • Candriam SCA's portfolio value rose 20% quarter-over-quarter to $7.82B.

Based on Candriam SCA's 13F filing for Q1 2019, filed 2 May 2019.